|
|
LifeSciences BC Events
This year’s 6th Annual Access to Innovation conference brought together 350+ Life Sciences leaders from all parts of B.C., Canada, the U.S. and the U.K. The conference is an opportunity for Life Sciences Leaders from research & academia, the health system and the local and global Life Sciences ecosystem to come together to learn and dialogue on topics of relevance to the sector - from B.C.’s world class scientific discovery and research, translating scientific innovation into companies and the health system, learnings and opportunities coming out of the COVID-19 pandemic, diversity, equity and inclusion, and opportunities to create and scale companies and policies to advance the sector.
We heard from The Hon. John Horgan, Premier of B.C., Hon. Ravi Kahlon, Minister of Jobs, Economic Recovery & Innovation, Dr. Reka Gustafson, Kory Wilson and notable scientific and business innovators such as Dr. Carl Hansen, Dr. Simon Pimstone, Scott Phillips, Dr. David Parkinson, Dr. Stephen Yip, Dr. Ali Tehrani, and Dr. James Taylor and sector leaders such as Gordon McCauley, Nancy Harrison, Pascal Spothelfer, Greg D’Avignon, Mary Ackenhusen, Mike Martin, Helen Sheridan and Dr. Fiona Dalton to name just a few of our esteemed speakers and participants. If we were left with one final thought coming out of the conference it is Optimism.
The BC Life Sciences sector is playing a critical role in both driving the economic recovery and competitiveness of B.C., while developing our innovative products, solution and services are leading COVID-19 responses and addressing many of the complex issues of our health system. With all stakeholders working together, there is no limit to what the Life Sciences sector can accomplish.
Life Science in the News
BC Business covered the session with Dr. Carl Hansen which you can read here.
Life Sciences in the Community
Next week we are co-hosting an event with our western life sciences counterparts Bioscience Association Manitoba (BAM) and BioAlberta. The Western Canada Partnership: Succeeding in Virtual Word Webinar presented by BAM, BIO Alberta and LifeSciences BC: Access Funding to Succeed is on March 2 @ 10:00 AM - 11:30 AM. Guest speakers: Dr. Eric Atkinson, Life Sciences Industrial Technology Advisor, NRC Industrial Research Assistance Program, Debra Boyce, Trade Commissioner, Global Affairs Canada, Joanne Jordan, Business Development and Partnerships Officer, BioTalent Canada, Beatriz Osorio, Trade Commissioner, Global Affairs Canada, Mike Pedlow, Partner, Torys LLP and Cheryl Reicin, Partner & Chair of Life Sciences Practice, Torys LLP. You can register here.
People on the Move
AbCellera announced this week the appointment of Dr. Murray McCutcheon, to VP, Corporate Development, from Head of Corporate Development. Congratulations Murray, we look forward to working with you, as always!
Have a good weekend everyone!
|
|
|
|
Xenon Pharmaceuticals Announces Promising New Pre-Clinical Data and Provides Clinical Overview of its XEN1101 Program at ASENT 2021 |
BURNABY, British Columbia, Feb. 22, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced that new pre-clinical data and a clinical overview of its XEN1101 program will be presented at ASENT 2021, the virtual annual meeting of the American Society for Experimental Neurotherapeutics. READ MORE
|
|
|
|
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results |
BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021... READ MORE
|
|
|
|
LifeSciences BC’s 6th Annual Access to Innovation Conference will generate important conversation between R&D, Academia, Industry and Government |
VANCOUVER, B.C., February 22, 2021 – A compelling and critical conversation will unfold over a two-day period at LifeSciences BC’s 6th ANNUAL ACCESS TO INNOVATION. The conference, virtual this year, on February 24 – 25, 2021, will host thought leaders from health research & innovation, academia, industry, and government as well as, key individuals in the life science sector from across the country and abroad. READ MORE
|
|
|
|
How a Canadian firm is accelerating the development of therapeutics |
Innovative Canadian companies are harnessing the power of sophisticated digital technologies to develop effective therapeutics in entirely new ways. This work involves advanced research at the nexus of multiple disciplines, including microbiology, biochemistry and computer science. READ MORE
|
|
|
|
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights |
February 24, 2021 – VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today issued its financial results for the fourth quarter and year ended December 31, 2020. Amounts, unless specified otherwise, are expressed in U.S. dollars. READ MORE
|
|
|
|
B.C. startup Eupraxia attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange |
February 24, 2021 | By Sean Silcoff, Technology Reporter, Globe and Mail | B.C.’s Eupraxia Pharmaceuticals Inc. is trying to accomplish something no other Canadian biotech startup has done in 18 years: go public solely on the Toronto Stock Exchange. The proposed $50-million IPO, underwritten by Raymond James, BMO Nesbitt Burns and Canaccord Genuity, is being closely watched by Canada’s life sciences sector. READ MORE
|
|
|
|
COVID-19: B.C. doctors seek to understand crushing fatigue months after recovery |
B.C. doctors treating long-haul COVID-19 patients are trying to figure out why some suffer from crushing fatigue months after recovery. Some patients experience relapses of their virus symptoms when they exercise, such as shortness of breath, coughing fits, loss of athletic ability and general malaise — all despite their tests showing no signs of illness. READ MORE
|
|
|
|
Single dose of Johnson & Johnson vaccine is 66% effective, say U.S. regulators |
Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday, paving the way for its approval for emergency use. The FDA's panel of independent experts is set to meet Friday to decide whether to approve the shot. While the panel is not bound to follow the advice of its experts, the FDA did so when authorizing the Pfizer-BioNTech and Moderna vaccines. READ MORE
|
|
|
|
Health professionals being recruited as B.C. ramps up for mass COVID-19 vaccination |
The B.C. government says more professionals are being recruited to vaccinate residents against COVID-19 in the coming months. Dentists, midwives, pharmacy technicians and some retired nurses are being hired to make sure there are enough people to vaccinate the general population. READ MORE
|
|
 |
Berkley Canada is specialty commercial insurance company that delivers exceptional customer service and industry leading expertise in both underwriting and claims. They have local underwriting and claims authority in Canada with access to the strength and stability of the W.R. Berkley Corporation, a Fortune 500 commercial lines property casualty insurance provider. The Life Science team provides a comprehensive primary liability product to address the complex risks faced by life sciences companies of all sizes.
|
|
|
|
WEX is developing a new class of non-opioid analgesics. The Company’s proprietary platform is Halneuron™ (TTX), a highly selective sodium channel blocker. WEX’s lead product Halneuron™ based on TTX is in Phase III clinical development for the treatment of cancer related pain and starting Phase III for chemotherapy induced neuropathic pain. WEX has conducted 15 clinical trials with TTX, with more than 700 subjects treated to date.
|
|
|
|
|
|
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION |
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here
|
|
|
|
Update: Student Work Placement Program now open to healthcare placements |
The Student Work Placement Program is now accepting applications for healthcare placements. Canada’s healthcare industry has a growing need to produce job-ready healthcare workers. There are 1,500 open spots available in 2020-21. WEBSITE
|
|
|
|
Posting A JOB on the LSBC Website |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? CONTACT: Sue Callaghan - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
